Naltrexone-3-salicylate (a Prodrug of Naltrexone): Synthesis and Pharmacokinetics in Dogs
- 1 January 1988
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 05 (2) , 113-115
- https://doi.org/10.1023/a:1015944302567
Abstract
Naltrexone-3-salicylate (3), a prodrug of naltrexone (1), was prepared by a simple procedure from naltrexone-3-acetylsalicylate (2). The plasma (dog and human) hydrolysis half-life of 3 was found to be approximately 30 min. Compound 2 was previously shown to hydrolyze in dog and human plasma with a fast deacetylation step to 3, followed by slower hydrolysis of 3 to 1 (t1/2, ∼30 min). Oral naltrexone bioavailability was greatly improved (∼30-fold) after oral administration of 3 to dogs, similar to the improvement observed after oral administration of 2. The half-life of naltrexone in dogs after oral administration of 3 was similar to that observed after oral administration of 2 (∼1 hr).This publication has 6 references indexed in Scilit:
- Improvement of the Oral Bioavailability of Naltrexone in Dogs: A Prodrug ApproachJournal of Pharmaceutical Sciences, 1987
- New Lipophilic Terbutaline Ester Prodrugs with Long Effect DurationPharmaceutical Research, 1984
- METABOLISM AND DISPOSITION OF NALTREXONE IN MAN AFTER ORAL AND INTRAVENOUS ADMINISTRATION1981
- Naltrexone and CyclazocineArchives of General Psychiatry, 1977
- ESTIMATION OF SYSTEMIC AVAILABILITY AND OTHER PHARMACOKINETIC PARAMETERS OF NALTREXONE IN MAN AFTER ACUTE AND CHRONIC ORAL-ADMINISTRATION1977
- Studies of EN-1639A (Naltrexone): A New Narcotic AntagonistAmerican Journal of Psychiatry, 1974